Affirm Stock: Follow Now and Buy Later or Buy Right Now? | AFRM Stock Analysis
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 28 Aug 2026, 17:15 UTC
- Recorded by Tahlil Plus
- 28 Aug 2026, 17:51 UTC
AI-generated source summary
The analysis highlights Affirm's (AFRM) strong revenue growth, which has doubled from approximately $200 million in 2019 to $3.67 billion in the trailing twelve months. Operating margin has also shown significant improvement, moving from negative 40% to a positive 20.96% over the period. The company's return on invested capital has also increased, reaching 3.35% and is projected to continue growing. The forward P/E ratio is trading at 16.43, which is within its historical range. The analysis suggests that the company is well-positioned for future expansion due to its business model and improving financial metrics. The intrinsic value per share is estimated at $87.69, suggesting the stock is currently undervalued at its market price of $77.71.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.